251635-59-3 Usage
Uses
Used in Synthetic Chemistry:
4-Methyl-2-(tributylstannyl)thiazole is used as a critical reagent for the stannylation of organic compounds in palladium-catalyzed cross-coupling reactions. This application is crucial in the creation of complex organic molecules, making it an essential component in the field of synthetic chemistry.
Used in Research Applications:
This organotin compound is also employed in various forms of research, where its unique properties and reactivity contribute to the advancement of scientific understanding and the development of new chemical processes and compounds. Its versatility in chemical syntheses makes it a valuable tool for researchers in the field.
Check Digit Verification of cas no
The CAS Registry Mumber 251635-59-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,5,1,6,3 and 5 respectively; the second part has 2 digits, 5 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 251635-59:
(8*2)+(7*5)+(6*1)+(5*6)+(4*3)+(3*5)+(2*5)+(1*9)=133
133 % 10 = 3
So 251635-59-3 is a valid CAS Registry Number.
InChI:InChI=1/C4H4NS.3C4H9.Sn/c1-4-2-6-3-5-4;3*1-3-4-2;/h2H,1H3;3*1,3-4H2,2H3;/rC16H31NSSn/c1-5-8-11-19(12-9-6-2,13-10-7-3)16-17-15(4)14-18-16/h14H,5-13H2,1-4H3
251635-59-3Relevant articles and documents
POTASSIUM CHANNEL MODULATORS
-
Paragraph 00289; 00290, (2018/01/17)
Provided are novel compounds of Formula (I): and pharmaceutically acceptable salts thereof, which are useful for treating a variety of diseases, disorders or conditions which can be affected by potassium channel modulation. Also provided are pharmaceutical compositions comprising the novel compounds of Formula (I), pharmaceutically acceptable salts thereof, and methods for their use in treating one or more diseases, disorders or conditions, associated with potassium channels.
TRICYCLIC COMPOUNDS
-
Paragraph 1823, (2014/06/25)
The present invention provides a compound of formula I or a pharmaceutically acceptable salt thereof; and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.